☰

Nicolai E. Savaskan

Affiliations: 
University of Erlangen-Nurnberg, Erlangen, Bayern, Germany 
 2007-2009 Brain Research Institute Universität Zürich, Zürich, ZH, Switzerland 
 2016- Cancer & Brain BiMECON 
Area:
axon guidance, glutamate signaling, gliomas, microenvironment
Website:
www.savaskan.net
Google:
"Nicolai Savaskan"
Mean distance: (not calculated yet)
 
Tree Publications Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

Parents

Sign in to add mentor
Bernhard K. Müller grad student 1997-1997 MPI Developmental Biology Tübingen
Robert Nitsch grad student 1996-2000 Charite Universitaetsmedizin Berlin, Humboldt Universitaet Berlin
Nullin Divecha post-doc 2003-2007 NKI Netherlands Cancer Institute Amsterdam
Wouter H. Moolenaar post-doc 2003-2007 NKI Netherlands Cancer Institute Amsterdam
Martin E. Schwab post-doc 2007-2009 ETH Zürich, Brain Research Institute

Children

Sign in to add trainee
Tina Sehm grad student 2011- Universitätsklinikum Erlangen
Anna Maria Reuss grad student 2012- University of Erlangen-Nuremberg, Erlangen, Germany
Ali Ghoochani grad student 2013- University of Erlangen-Nuremberg, Erlangen, Germany
Daishi Chen grad student 2014- University of Erlangen-Nurnberg
Susan Meier grad student 2000-2004 Charité Berlin
Tanja Velmans grad student 2004-2005 Netherlands Cancer Institute - Amsterdam
Lena Harder grad student 2005-2006 NKI Netherlands Cancer Institute Amsterdam
Maria Gierisch grad student 2009-2010 University of Zurich, Institute of Cancer
Lisa Moritz grad student 2009-2011 Charité Berlin
Philip Bittermann Rummel grad student 2009-2014 University of Erlangen-Nurnberg
Stefan W. Hock grad student 2011-2014 University of Erlangen-Nurnberg
Anne Katharina Wirth grad student 2012-2014 University of Erlangen-Nuremberg, Erlangen, Germany
Jörg Otte grad student 2013-2014 University of Erlangen-Nuremberg, Erlangen, Germany
Zheng Fan grad student 2011-2015 University of Erlangen-Nurnberg
Katharina Friedlein grad student 2012-2016 University of Erlangen-Nurnberg
Tengfei Xu grad student 2012-2016 University of Erlangen-Nurnberg
Eduard Yakubov grad student 2013-2017 Friedrich-Alexander University Erlangen

Collaborators

Sign in to add collaborator
Manfred Rauh collaborator 2011- University of Erlangen-Nurnberg
Anja Bräuer collaborator 2000-2010 Carl von Ossietzky University of Oldenburg
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yakubov E, Ghoochani A, Savaskan N. (2023) Editorial: Ferroptosis in malignant brain tumors. Frontiers in Oncology. 13: 1276971
Yakubov E, Schmid S, Hammer A, et al. (2023) Ferroptosis and PPAR-gamma in the limelight of brain tumors and edema. Frontiers in Oncology. 13: 1176038
Dahlmanns M, Dahlmanns JK, Savaskan N, et al. (2023) Glial Glutamate Transporter-Mediated Plasticity: System x/xCT/SLC7A11 and EAAT1/2 in Brain Diseases. Frontiers in Bioscience (Landmark Edition). 28: 57
Ackermann A, Çapcı A, Buchfelder M, et al. (2021) Chemical hybridization of sulfasalazine and dihydroartemisinin promotes brain tumor cell death. Scientific Reports. 11: 20766
Yakubov E, Eibl T, Hammer A, et al. (2021) Therapeutic Potential of Selenium in Glioblastoma. Frontiers in Neuroscience. 15: 666679
Reuss AM, Groos D, Buchfelder M, et al. (2021) The Acidic Brain-Glycolytic Switch in the Microenvironment of Malignant Glioma. International Journal of Molecular Sciences. 22
Reuss AM, Groos D, Ghoochani A, et al. (2021) MCT4 Promotes Tumor Malignancy in F98 Glioma Cells. Journal of Oncology. 2021: 6655529
Ackermann A, Karagöz AÇ, Ghoochani A, et al. (2017) Cytotoxic profiling of artesunic and betulinic acids and their synthetic hybrid compound on neurons and gliomas. Oncotarget. 8: 61457-61474
Chen D, Rauh M, Buchfelder M, et al. (2017) The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas. Oncotarget. 8: 51164-51176
Dahlmanns M, Yakubov E, Chen D, et al. (2017) Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool. Cell Death Discovery. 3: 17030
See more...